Early research (Phase 1)Not Yet RecruitingNCT07807449
What this trial is testing
Safety and Preliminary Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Adults Aged 18 Years and Older
Who this might be right for
Respiratory Syncytial Virus (RSV)
Yikang Biotech (Suzhou) Co., Ltd. 128